Skip to contentP
Panacea Life Sciences Holdings, Inc.
P
PLSHPanacea Life Sciences Holdings, Inc. Q3 2017 · 10-Q
Revenue$0.00$0.00— vs Q3 2016 Net Income-$717.82K-$717.82KN/M vs Q3 2016 EPS Diluted-$0.02-$0.02N/M vs Q3 2016 Operating Income-$490,207N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Panacea Life Sciences Holdings, Inc. · CIK 1552189 · Engraved from SEC EDGAR
derived
ended Sep 30, 2017 · filed Nov 20, 2017 · 51 d after period end